Clinical status of potential drugs used for COVID-19 treatment and recent advances in new therapeutics - A review

clinical status of covid drugs

Authors

  • Kalpa Mandal University of Delhi
  • Meenakshi Singh Galgotias University
  • Charu Chandra University of Delhi
  • Indraj Kumar Kumawat University of Delhi

Keywords:

Corona Virus, SARS-CoV-2, Drug repurposing, New therapeutics, deoxyglucose, heterocyclic drugs, Covid-19, Clinical trials, Clinical output

Abstract

COVID-19, a perilous disease caused by SARS-CoV-2, has brought a massive damage to humankind, and turned into a global catastrophe. It was first reported in Wuhan, China in December 2019 and since then has been a constant source of worry for the scientists and the medical world, due to the carnage it has caused globally. Extensive clinical studies are being carried to explore drug therapy and prophylaxis to combat this pestilence.  It is still an excessively big challenge for the scientists and pharmacological industry to develop potential drugs for the treatment of this deadly virus. At present though no specific drug has been identified as a perfect cure for this zoonotic disease, medical practitioners are using the therapy of repurposing of drugs for the treatment. Systemic research was carried out through e-resources to identify drugs for the treatment of COVID-19. A recent proposal of 2-DG drug as a cure for COVID-19 has also been discussed in this review.

Downloads

Published

2021-09-21

How to Cite

Mandal, K., Singh, M., Chandra, C., & Kumawat, I. K. (2021). Clinical status of potential drugs used for COVID-19 treatment and recent advances in new therapeutics - A review. Chemical Biology Letters, 8(3), 117–128. Retrieved from https://pubs.thesciencein.org/journal/index.php/cbl/article/view/277

Issue

Section

Review Articles